DK
Deepak Komaregowda
About Deepak Komaregowda
Data last updated:
Deepak Komaregowda is a Nominee Director at Symbio Generrics India Private Limited (since 2022), Nominee Director at Daya General Hospital Limited (since 2025) and Nominee Director at Elixa Technologies Private Limited (since 2025), and holds 2 more current directorships. The companies operate in Pharma, Healthcare and Chemicals and Materials. The 4 current companies with reported revenue have a combined latest revenue of ₹925 Cr; the largest is Symbio Generrics India Private Limited at ₹435 Cr (FY 2025). Earlier, Deepak Komaregowda was a Nominee Director at I-Nurture Education Solutions Private Limited (2012–2024) and Director at Inurture 360 Careers Private Limited (2015–2024) and 17 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nominee Director | 30 Mar 2022 | 2011 | ₹435 Cr (FY 2025) | Active | |
| Nominee Director | 03 Sep 2025 | 1977 | ₹189 Cr (FY 2025) | Active | |
| Nominee Director | 09 Jul 2025 | 2017 | ₹165 Cr (FY 2025) | Active | |
| Nominee Director | 06 Dec 2019 | 1978 | ₹136 Cr (FY 2025) | Active | |
| Partner | 20 Jun 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nominee Director | 01 Aug 2012 | 2004 | ₹103 Cr (FY 2022) | Active | |
| Director | 30 Sep 2015 | 2015 | ₹1.78 Cr (FY 2023) | Active | |
| Nominee Director | 29 Aug 2013 | 2007 | ₹213 Cr (FY 2025) | Active | |
| Nominee Director | 12 May 2015 | 2008 | ₹5.36 Cr (FY 2025) | Active | |
| Director | 09 Feb 2017 | 2016 | ₹14.64 Cr (FY 2025) | Active | |
| Director | 20 Apr 2013 | 2010 | ₹25.22 Cr (FY 2025) | Active | |
| Director | 23 Jul 2010 | 2001 | ₹142 Cr (FY 2025) | Active | |
| Nominee Director | 15 May 2015 | 2000 | ₹321 Cr (FY 2025) | Active | |
| Nominee Director | 29 Aug 2013 | 2010 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Deepak Komaregowda
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deepak Komaregowda
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepak Komaregowda
Deepak Komaregowda currently holds 5 directorships: Symbio Generrics India Private Limited (Nominee Director, since 30 Mar 2022, revenue ₹435 Cr (FY 2025)); Daya General Hospital Limited (Nominee Director, since 03 Sep 2025, revenue ₹189 Cr (FY 2025)); Elixa Technologies Private Limited (Nominee Director, since 09 Jul 2025, revenue ₹165 Cr (FY 2025)); Naari Pharma Private Limited (Nominee Director, since 06 Dec 2019, revenue ₹136 Cr (FY 2025)); Sapiantsages Partners Llp (Partner, since 20 Jun 2022).
Deepak Komaregowda was first appointed on 23 Jul 2010 as Director at Nmsworks Software Private Limited. The most recent appointment on record is 03 Sep 2025 at Daya General Hospital Limited.
The 4 current companies of Deepak Komaregowda that report revenue have a combined latest revenue of ₹925 Cr: Symbio Generrics India Private Limited ₹435 Cr (FY 2025); Daya General Hospital Limited ₹189 Cr (FY 2025); Elixa Technologies Private Limited ₹165 Cr (FY 2025); Naari Pharma Private Limited ₹136 Cr (FY 2025).
Deepak Komaregowda held 19 earlier board appointments: I-Nurture Education Solutions Private Limited (Nominee Director, 01 Aug 2012 to 05 Mar 2024); Inurture 360 Careers Private Limited (Director, 30 Sep 2015 to 04 Nov 2024); Skanray Technologies Limited (Nominee Director, 29 Aug 2013 to 17 Oct 2025); Global Delight Technologies Private Limited (Nominee Director, 12 May 2015 to 07 Oct 2025); Gge Services Private Limited (Director, 09 Feb 2017 to 01 Aug 2024); and 14 more.
The current boards of Deepak Komaregowda's companies include Akash Suresh Puranik (Symbio Generrics India Private Limited), Akash Suresh Puranik (Symbio Generrics India Private Limited), Kannan Natraj Sharma (Symbio Generrics India Private Limited), Salim Sadiq Shaikh (Symbio Generrics India Private Limited), Abdul Jebbar (Daya General Hospital Limited), Ambalathveettil Kunnamthodath Shamsudeen (Daya General Hospital Limited), among others.